KR102270315B1 - 재조합 결합 단백질 및 그의 용도 - Google Patents

재조합 결합 단백질 및 그의 용도 Download PDF

Info

Publication number
KR102270315B1
KR102270315B1 KR1020197009396A KR20197009396A KR102270315B1 KR 102270315 B1 KR102270315 B1 KR 102270315B1 KR 1020197009396 A KR1020197009396 A KR 1020197009396A KR 20197009396 A KR20197009396 A KR 20197009396A KR 102270315 B1 KR102270315 B1 KR 102270315B1
Authority
KR
South Korea
Prior art keywords
ala
leu
gly
asp
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020197009396A
Other languages
English (en)
Korean (ko)
Other versions
KR20190050802A (ko
Inventor
클라라 메츠
울리케 피들러
이그나시오 도라도
헤이크 마리아 스트로벨
Original Assignee
몰리큘라 파트너스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 몰리큘라 파트너스 아게 filed Critical 몰리큘라 파트너스 아게
Publication of KR20190050802A publication Critical patent/KR20190050802A/ko
Application granted granted Critical
Publication of KR102270315B1 publication Critical patent/KR102270315B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020197009396A 2016-09-22 2017-09-20 재조합 결합 단백질 및 그의 용도 Expired - Fee Related KR102270315B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16190221.8 2016-09-22
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (2)

Publication Number Publication Date
KR20190050802A KR20190050802A (ko) 2019-05-13
KR102270315B1 true KR102270315B1 (ko) 2021-06-29

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197009396A Expired - Fee Related KR102270315B1 (ko) 2016-09-22 2017-09-20 재조합 결합 단백질 및 그의 용도

Country Status (20)

Country Link
US (2) US10717772B2 (cg-RX-API-DMAC7.html)
EP (1) EP3515933B9 (cg-RX-API-DMAC7.html)
JP (1) JP6976335B2 (cg-RX-API-DMAC7.html)
KR (1) KR102270315B1 (cg-RX-API-DMAC7.html)
CN (1) CN109790206A (cg-RX-API-DMAC7.html)
AR (1) AR109680A1 (cg-RX-API-DMAC7.html)
AU (1) AU2017331329B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019005587A2 (cg-RX-API-DMAC7.html)
CA (1) CA3036301C (cg-RX-API-DMAC7.html)
CL (1) CL2019000729A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019002609A2 (cg-RX-API-DMAC7.html)
ES (1) ES2953516T3 (cg-RX-API-DMAC7.html)
IL (1) IL265489B (cg-RX-API-DMAC7.html)
MX (1) MX377424B (cg-RX-API-DMAC7.html)
MY (1) MY196882A (cg-RX-API-DMAC7.html)
NZ (1) NZ751689A (cg-RX-API-DMAC7.html)
PH (1) PH12019500596B1 (cg-RX-API-DMAC7.html)
SA (1) SA519401369B1 (cg-RX-API-DMAC7.html)
WO (1) WO2018054971A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201901592B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3980452A1 (en) * 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
CA3139164A1 (en) * 2019-06-04 2020-12-10 Molecular Partners Ag Recombinant fap binding proteins and their use
KR20220016944A (ko) 2019-06-04 2022-02-10 몰리큘라 파트너스 아게 개선된 안정성을 갖는 설계된 안키린 반복 도메인
JP2022535564A (ja) * 2019-06-04 2022-08-09 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
MX2022013945A (es) 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
AU2021271131A1 (en) * 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use
US20240108746A1 (en) 2020-12-16 2024-04-04 Molecular Partners Ag Novel slow-release prodrugs
US20240317852A1 (en) 2021-03-09 2024-09-26 Molecular Partners Ag Novel darpin based cd33 engagers
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
CA3211368A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based cd123 engagers
EP4305063A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Protease cleavable prodrugs
WO2023110983A1 (en) 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
CA3262553A1 (en) 2022-08-01 2024-02-08 Molecular Partners Ag REHEARSAL AREAS DESIGNED WITH MODIFIED CHARGES AND THEIR USE
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules
IL322519A (en) 2023-02-17 2025-10-01 Ablynx Nv Polypeptides that bind to the neonatal fc receptor
EP4673159A1 (en) 2023-02-27 2026-01-07 Molecular Partners AG Darpins for use in reducing renal accumulation of drugs
JP2026524079A (ja) 2023-06-06 2026-07-17 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換えcd2結合タンパク質及びその使用
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
CN122438868A (zh) 2024-01-05 2026-07-21 分子合作伙伴股份公司 多特异性结合蛋白
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025163082A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026013280A1 (en) * 2024-07-11 2026-01-15 Johann Wolfgang Goethe-Universität Frankfurt am Main Designed ankyrin repeat proteins binding p53, and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015537044A (ja) 2012-11-30 2015-12-24 モレキュラー パートナーズ アクチェンゲゼルシャフト 少なくとも2つの抗her2反復ドメインを含む結合タンパク質

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
EP2518142B1 (en) * 2001-08-24 2015-07-15 UVic Industry Partnerships Inc. Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
KR20070085314A (ko) 2004-11-12 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 재조합 뉴캐슬 질환 바이러스
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
CA2706425A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
WO2012149439A2 (en) 2011-04-29 2012-11-01 Janssen Biotech, Inc. Il4/il13 binding repeat proteins and uses
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2906591A1 (en) * 2012-10-15 2015-08-19 Universität Zürich Bispecific her2 ligands for cancer therapy
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) * 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015537044A (ja) 2012-11-30 2015-12-24 モレキュラー パートナーズ アクチェンゲゼルシャフト 少なくとも2つの抗her2反復ドメインを含む結合タンパク質

Also Published As

Publication number Publication date
CA3036301C (en) 2021-04-20
SA519401369B1 (ar) 2022-12-22
AU2017331329A1 (en) 2019-04-04
KR20190050802A (ko) 2019-05-13
US20180155402A1 (en) 2018-06-07
CA3036301A1 (en) 2018-03-29
IL265489B (en) 2021-07-29
WO2018054971A1 (en) 2018-03-29
JP2019531093A (ja) 2019-10-31
EP3515933B9 (en) 2023-08-16
EP3515933A1 (en) 2019-07-31
US20210130420A1 (en) 2021-05-06
MX2019003298A (es) 2019-09-26
CO2019002609A2 (es) 2019-05-31
EP3515933B1 (en) 2023-06-07
CL2019000729A1 (es) 2019-06-14
MY196882A (en) 2023-05-08
RU2019111628A (ru) 2020-10-19
RU2019111628A3 (cg-RX-API-DMAC7.html) 2020-10-30
PH12019500596B1 (en) 2024-02-21
ES2953516T3 (es) 2023-11-14
NZ751689A (en) 2021-07-30
JP6976335B2 (ja) 2021-12-08
ZA201901592B (en) 2021-04-28
BR112019005587A2 (pt) 2019-06-11
AR109680A1 (es) 2019-01-09
IL265489A (en) 2019-05-30
PH12019500596A1 (en) 2019-07-29
CN109790206A (zh) 2019-05-21
US10717772B2 (en) 2020-07-21
EP3515933C0 (en) 2023-06-07
AU2017331329B2 (en) 2020-10-29
MX377424B (es) 2025-03-10

Similar Documents

Publication Publication Date Title
AU2017331329B2 (en) Recombinant binding proteins and their use
AU2021286418B2 (en) Designed ankyrin repeat domains with binding specificity for serum albumin
KR102290592B1 (ko) Her2에 대항하는 적어도 두 개 이상의 반복 도메인을 포함하는 결합 단백질
KR20230120139A (ko) 재조합 cd3 결합 단백질 및 이의 용도
RU2778346C2 (ru) Рекомбинантные связывающие белки и их применение
HK40006908A (en) Recombinant binding proteins and their use
HK40006908B (en) Recombinant binding proteins and their use
HK1244009B (en) Designed ankyrin repeat domains with binding specificity for serum albumin

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
A302 Request for accelerated examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20240624

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20240624